Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,180,550 | 2,000,067 | 712,582 | 2,518,142 | 2,308,664 |
| Marketable Securities | 390,000 | 401,776 | 805,907 | 572,285 | 389,300 |
| Receivables | 3,028,050 | 3,520,890 | 3,419,300 | 3,216,014 | 3,076,082 |
| Inventories | 2,137,800 | 2,071,156 | 1,921,960 | 1,898,390 | 1,902,814 |
| Other current assets | 0 | 1 | 1 | 1 | 1 |
| TOTAL | $7,736,400 | $7,993,889 | $6,859,750 | $8,204,832 | $7,676,861 |
| Non-Current Assets | |||||
| PPE Net | 4,233,450 | 4,120,288 | 3,825,138 | 3,801,096 | 3,574,971 |
| Investments And Advances | 300,150 | 295,901 | 289,588 | 319,920 | 310,128 |
| Intangibles | 427,350 | 320,357 | 319,020 | 321,110 | 218,432 |
| Other Non-Current Assets | 403,650 | 677,626 | 888,732 | 1,012,733 | 922,184 |
| TOTAL | $5,364,600 | $5,414,172 | $5,322,478 | $5,454,859 | $5,025,714 |
| Total Assets | $13,101,000 | $13,408,060 | $12,182,230 | $13,659,690 | $12,702,570 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 68,400 | 61,671 | 60,047 | 159,662 | 93,933 |
| Accounts payable and accrued liabilities | 669,300 | 810,083 | 553,146 | 733,138 | 573,290 |
| Other current liabilities | 4,717,650 | 4,739,584 | 4,742,709 | 4,627,085 | 4,582,588 |
| TOTAL | $6,238,800 | $6,308,103 | $6,074,845 | $6,081,902 | $5,743,779 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 661,650 | 629,474 | 591,156 | 587,909 | 529,603 |
| TOTAL | $663,150 | $631,296 | $593,079 | $588,802 | $531,243 |
| Total Liabilities | $6,901,950 | $6,939,399 | $6,667,924 | $6,670,704 | $6,275,022 |
| Shareholders' Equity | |||||
| Common Shares | 76,500 | 77,469 | 76,908 | 77,376 | 77,532 |
| Retained earnings | 6,158,400 | 6,457,269 | 5,334,753 | 6,966,221 | 6,381,033 |
| Other shareholders' equity | -34,850 | -65,076 | 104,643 | -53,610 | -30,013 |
| TOTAL | $6,199,050 | $6,468,662 | $5,514,304 | $6,988,987 | $6,427,552 |
| Total Liabilities And Equity | $13,101,000 | $13,408,061 | $12,182,228 | $13,659,691 | $12,702,574 |